Hypoglycosylated #MUC1 was ⬆️ in bile duct tissue of pts with #PSC and ⬆️ ⬆️ in cholangiocarcinoma ✅ Hypoglycosylated #MUC1 can serve as a biomarker of disease severity Stay tuned 📻📡 for more from our team 🕵️‍♀️ 🙏🏻 to @AmCollegeGastro for pilot grant award

So well deserved @oridamas on your @ShermanPrize!!! Congrats from all your friends at @MayoClinicFLGIH Continue shining ✨

Thank you @DCharabaty for visiting us @MayoClinicFLGIH ☀️ 🏝️ ✅ Great lecture ✅ Great advice ✅ Fun times Come back again soon! @ibdgijami @FarrayeIBD @JGubatanMD @CrohnsDoc

Lebanese national lung cancer awareness campaign الحملة الوطنية للتوعية من سرطان الرئة @mophleb

Proud of this outstanding work to reduce the burden of lung cancer in Lebanon being led by @ArafatTfayli and @mophleb @RKNassereldine

Dietary fiber isn’t a single molecule Instead of focusing on whether a source of fiber is soluble or insoluble, it’s better to focus on: 🔸Solubility 🔸Fermentability 🔸Viscosity @nehagastrord

How to talk to your IBD pt about diet and fiber per @nehagastrord @ucsfibd Updates.

Great work to organize our yearly course thanks to Jana Al Hashash Jami Kinnucan Frank Farraye Mike Picco

@LinChangMD from @UCLAHealth on the high prevalence of #IBS in #IBD @MayoClinicFLGIH Mayo Clinic Updates in Inflammatory Bowel Disease 2025 annual conference. A very challenging co-occurrence to manage!

Look at all these gifts and CEO level handshake @MayoClinicFLGIH gave me for making it out to Jacksonville! Wonderful IBD course hosted by the lovely @JHashashMD @ibdgijami and Dr Ferraye. Disclaimer: I had to share these gifts with my co-speakers 😉

Here we go! 2nd Annual @MayoClinicFLGIH #IBD Updates hosting colleagues and friends across the country in person and virtually @FarrayeIBD @JHashashMD @DavidBruiningMD @JLeightonMD @JGubatanMD

#ACG2025 #IBDPosterTour Hypoglycosylated #MUC1 as biomarker of post-op #Crohns recurrence? 🧬MUC1: role in mucosal barrier integrity ⬆️abn MUC1 from Rutgeerts i0 -> i4 🔺Assoc recurrence severity & abn MUC1 🔮Stratify progressive risk of i0-i1 (+high MUC1) ? 🔮Therapeutic 🎯?

Happiest with my hands on a scope 🥹 THANKYOU #ACG2025 and @JHashashMD for giving me this moment to cherish. Hoping this is my first of many bands! 🙏🏼

Diet advice should be tailored based on clinical scenarios that patients with #IBD encounter 🗣 Tips and tricks from @JHashashMD ✅During flare-up: 🔸Individualize (all-formula diet, partial enteral nutrition) 🔸Consider a specific carbohydrate diet 🔸Mediterranean diet as

Today I had the pleasure of meeting an inspiring figure at the #ACG, easily the highlight of the day!

CLEAR-IE - largest multicenter registry on percutaneous mechanical aspiration in R infective endocarditis now published in @JACCJournals - high procedural success, 93% neg blood cx, adverse events likely related to complications from IE esp hypoxia and shock - Prospective studies

Oncall w several #IBD pts getting admitted & thank goodness our new #GIFellow from @USF says he learned from @jensemineriomd ⚡️at USF! So relieved 😌. Then I realize how nice it is that we teach our future generations and they us. @CrohnsColitisFn @MN_GIMD @DCharabaty @JHashashMD

An important slide on IBD monitoring @AmJGastro https://t.co/WzSFKwhrnN

Overview of IBD biology and treatment mechanisms ⚙️🎯 📸: https://t.co/ZrIybx6ZXd

Monitoring Inflammatory Bowel Disease Activity: When, How, and Why Jill Gaidos, MD, FACG & Jana Hashash, MD, MSc, FACG 📕 https://t.co/uE3zJs5qNk @JillGaidosMD @JHashashMD @MLongMD @JasmohanBajaj